Press "Enter" to skip to content

New patent for Epizyme Inc drug TAZVERIK

0
Copyright © DrugPatentWatch. Originally published at New patent for Epizyme Inc drug TAZVERIK

Annual Drug Patent Expirations for TAZVERIK
Annual Drug Patent Expirations for TAZVERIK

Tazverik is a drug marketed by Epizyme Inc and is included in one NDA. There are twenty-one patents protecting this drug.

This drug has two hundred and fifty-five patent family members in thirty-eight countries.

The generic ingredient in TAZVERIK is tazemetostat hydrobromide. Additional details are available on the tazemetostat hydrobromide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Epizyme Inc drug TAZVERIK
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!